CFO Kevin Hammons said on the for-profit system’s Oct. 26 earnings call that on the Medicare side they are seeing a continued shift out of fee-for-service into Medicare Advantage, “and that always continues to pressure the revenue, because we collect less on MA compared to traditional fee-for-service.”
Here is a look at CHS’ payer mix by net patient revenues for the quarter ended Sept. 30 compared to the same period last year:
Q3 2023:
Commercial: $1.5 billion (47.9%)
Medicare: $608 million (19.7%)
Medicare Advantage: $498 million (16.1%)
Medicaid: $456 million (14.8%)
Self-pay: $45 million (1.5%)
Q3 2022:
Commercial: $1.4 billion (47.8%)
Medicare: $644 million (21.3%)
Medicare Advantage: $479 million (15.8%)
Medicaid: $449 million (14.9%)
Self-pay: $7 million (0.2%)
Here is a look at CHS’ payer mix by net patient revenues for the nine months ended Sept. 30:
2023:
Commercial: $4.4 billion (47.7%)
Medicare: $1.9 billion (20.2%)
Medicare Advantage: $1.6 billion (16.8%)
Medicaid: $1.3 billion (14.3%)
Self-pay: $92 million (1%)
2022:
Commercial: $4.2 billion (46.9%)
Medicare: $1.9 billion (21.3%)
Medicare Advantage: $1.5 billion (16.2%)
Medicaid: $1.4 billion (15%)
Self-pay: $60 million (0.6%)
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
